UNSPSC 51313703: Isothipendyl

This classification denotes a histamine antagonist with the molecular formula C16H19N3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier WVZ7K9P0JY, chemically known as 10h-pyrido(3,2-b)(1,4)benzothiazine-10-ethanamine, n,n,alpha-trimethyl- but generally known as isothipendyl, which bears US NIH Compound Identifier 3781. European Medicines Agency schedules Isothipendyl in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08339MIG.

UNSPSC 51313703 Isothipendyl, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The single opportunity in the available record—Seminole County, Florida's IFB 60459723LAS—solicits naloxone and drug deactivation systems for community health initiatives, which falls outside the pharmaceutical ingredient scope of the code's nominal classification. The mismatch suggests either a data-entry error in the source system or that this code sees minimal relevant recent activity in state and local procurement.

Seminole County posted the opportunity on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding with quarterly deliveries to its Community Health Building in Sanford, Florida. The IFB closed on July 26, 2023—a date inconsistency in the source record—and required E-Verify compliance, drug-free workplace certification, standard commercial insurance, and potential FEMA funding compliance. The contract offered a two-year initial term with a one-year renewal option and included a three-month probationary termination window. No set-aside designations or disadvantaged-enterprise restrictions were specified. Without additional opportunities in the block, geographic concentration or issuing-body mix cannot be characterized reliably under this code.